Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, 3.24 - Office Visits, 3.20 - Infusion Therapy, and for prescription drugs, 3.28 and Pharmacy Benefits.
Appears in 9 contracts
Samples: Subscriber Agreement, Subscriber Agreement, Subscriber Agreement
Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, 3.24 - Office Visits, 3.20 3.21 - Infusion Therapy, and for prescription drugs, Section 3.28 and Pharmacy Benefits.
Appears in 6 contracts
Samples: Subscriber Agreement, Subscriber Agreement, Subscriber Agreement
Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, 3.24 - Office Visits, 3.20 - Infusion Therapy, and for prescription drugs, 3.28 and Pharmacy Benefits.
Appears in 1 contract
Samples: Subscriber Agreement
Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, 3.24 - Office Visits, 3.20 3.19 - Infusion Therapy, and for prescription drugs, 3.28 and Pharmacy Benefits.
Appears in 1 contract
Samples: Subscriber Agreement
Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, 3.24 3.23 - Office Visits, 3.20 3.19 - Infusion Therapy, and for prescription drugs, 3.28 3.27 and the Summary Pharmacy Benefits.
Appears in 1 contract
Samples: Subscriber Agreement
Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, 3.24 - Office Visits, 3.20 - Infusion Therapy, and for prescription drugs, 3.28 and the Summary Pharmacy Benefits.
Appears in 1 contract
Samples: Subscriber Agreement